From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine.
Despite the promises made that genomic sequencing would transform therapy by introducing a new era of personalized medicine, relatively few tangible breakthroughs have been made. This has led to the recognition that complex interactions at multiple spatial, temporal, and organizational levels may often combine to produce disease. Understanding this complexity requires that existing and future models are used and interpreted within a framework that incorporates knowledge derived from investigations at multiple levels of biological function. It also requires a computational infrastructure capable of dealing with the vast quantities of data generated by genomic approaches. In this review, we discuss the use of molecular modeling to generate quantitative and qualitative insights at the smallest scales of the systems biology hierarchy, how it can play an important role in the development of a systems understanding of disease and in the application of such knowledge to help discover new therapies and target existing ones on a personal level.
Centre for Computational Science, University College London, London, UK.
David W
DW
Wright
Shunzhou
S
Wan
Nour
N
Shublaq
Stefan J
SJ
Zasada
Peter V
PV
Coveney
D019380:Anti-HIV Agents / Q000627:therapeutic use; D020029:Base Pairing; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000378:metabolism; D023281:Genomics; D006678:HIV / Q000201:enzymology / Q000235:genetics / Q000378:metabolism; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D008958:Models, Molecular; D057285:Precision Medicine; D015398:Signal Transduction
D019380:Anti-HIV Agents; D066246:ErbB Receptors